Finally, the ability of PrC-210 to completely suppress both CI kidney damage over 30 hours (Figure 5A), and warm-reperfusion kidney injury,24 would allow PrC-210 to be used in a variety of transplant and surgical settings to reduce IR injury. This evidence concerns the gene PPRC1 and Nephropathy.